Evidence map›Paper›PMID 32600286›Full record

ArticleBMC nephrology2020

Nephrotic syndrome due to preeclampsia before 20 weeks of gestation: a case report.

Tomo Suzuki, Daisuke Ichikawa, Mayumi Nakata, Shiika Watanabe, Wei Han, Kaori Kohatsu, Sayuri Shirai, Naohiko Imai, Junki Koike, Yugo Shibagaki

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Atypical Preeclampsia before 20 Weeks of Gestation-A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tomo SuzukiDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 216-8511, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan. t2suzuki@marianna-u.ac.jp.ORCID 0000-0001-5536-1741
Daisuke IchikawaDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 216-8511, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Mayumi NakataDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 216-8511, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Shiika WatanabeDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 216-8511, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Wei HanDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 216-8511, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Kaori KohatsuDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 216-8511, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Sayuri ShiraiDepartment of Nephrology and Hypertension, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Kanagawa, Japan.
Naohiko ImaiDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 216-8511, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan.
Junki KoikeDepartment of Diagnostic Pathology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Yugo ShibagakiDivision of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, 216-8511, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan.
St. Marianna University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreeclampsia (PE) refers to the development of hypertension and new-onset proteinuria or progressive organ damage (especially kidney) in a previously normotensive pregnant women after 20 weeks of gestation. Thus, new-onset nephrotic syndrome due to PE before 20 weeks of gestation seems to be rare, making its diagnosis difficult in this time period. CASE PRESENTATION: A 28-year-old woman presented with a new-onset nephrotic syndrome at 16 weeks of gestation. A high dose of oral glucocorticoids (prednisolone, 40 mg) was initiated for presumed glomerulonephritis since she presented with severe nephrotic syndrome before 20 weeks of gestation, however, the treatment was not effective. At 21 weeks of gestation, we confirmed that the soluble fms-like tyrosine kinase-1 (sFlt-1)/placental growth factor (PlGF) ratio was very high (sFlt-1, 13,400 pg/mL; PlGF, 21.9 pg/mL; serum sFlt-1/PlGF ratio 611.9). Therefore, we diagnosed nephrotic syndrome due to PE, and oral glucocorticoids were discontinued. After she underwent a cesarean section at 24 weeks & 3 days, we performed a kidney biopsy. Focal segmental sclerotic lesions with epithelial cell hyperplasia and foam cells in the tubular poles were seen on light microscopy. On immunofluorescence tests, C4d staining showed linear peripheral patterns in the glomeruli. Electron microscopy revealed diffuse subendothelial edema with focal foot process effacement. The histological diagnosis was severe glomerular endotheliosis with focal segmental glomerulosclerosis. Furthermore, the histology of placenta was consistent with PE. Eight months after delivery, her proteinuria disappeared completely.

conclusionsWe not only confirmed an abnormal serum sFlt-1/PlGF ratio but also presented the histology compatible with pure PE in the kidney and placenta in a case of nephrotic syndrome before 20 weeks of gestation. The serum sFlt-1/PlGF ratio may be useful in determining the treatment strategy for atypical cases of pregnant women with nephrotic syndrome, particularly before 20 weeks of gestation.

Indexed as

AdultAntihypertensive AgentsCesarean SectionEdemaFemaleFurosemideGlomerulosclerosis, Focal SegmentalGlucocorticoidsHumansNephrotic SyndromePlacenta Growth FactorPleural EffusionPrednisolonePre-EclampsiaPregnancyPregnancy Trimester, SecondAntihypertensive AgentsFLT1 protein, humanFurosemideGlucocorticoidsPlacenta Growth FactorPrednisoloneSerum Albumin, HumanSodium Potassium Chloride Symporter InhibitorsVascular Endothelial Growth Factor Receptor-1Nephrotic syndromePlacental growth factorPreeclampsiaSoluble fms-like tyrosine kinase-1

Identifiers

PMID32600286
PMCPMC7322849
OpenAlexW3037652113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.